Cannabis Rescheduling

What to Expect From the DEA’s Cannabis Rescheduling Hearing Transcripts, Final Briefs

A law judge’s recommendation may not come down to whether anti-rescheduling parties proved a Schedule I listing, but whether they disproved the government’s Schedule III evidence.

Idaho’s Cannabis Legalization Campaign Effort Leads CBT’s Top Stories in July

Activists submitted signatures to the state secretary at the beginning of the month, after collecting more than double the required number for their petition.

DOJ Head Sidesteps Questions on Schedule III Order, Adult-Use Cannabis

Todd Blanche, Trump’s nominee to be the U.S. attorney general, answered questions for the record about his stances on rescheduling, 280E and enforcement.

Anti-Rescheduling Groups Attempting to Stay Schedule III Order Call Government’s Response ‘Meritless’

A drug testing group and pharmaceutical company asked a federal court to stay the order, claiming the DOJ has no defense other than diversions.

17 Senate Democrats File Bill to Federally Legalize Cannabis

The Cannabis Administration and Opportunity Act would deschedule cannabis, removing it from the Controlled Substances Act.

Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I

Wyoming Attorney General Keith G. Kautz announced that he won’t loosen restrictions on cannabis after there was little public interest in doing so.

Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says

The Department of Justice argued that anti-rescheduling groups attempting to stay a Schedule III order have ‘pocketbook interests’ in prohibition.

‘DEA Comes Out Swinging in Cannabis Rescheduling Hearing' Leads CBT’s Top Stories in June

CBT provided an in-the-courtroom analysis of the DEA’s first witness’s testimony in support of the Schedule III proposed rule.

Prohibitionists Punch Back at Cannabis Rescheduling Hearing

Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.

DEA Comes Out Swinging in Cannabis Rescheduling Hearing

The government argued in support of currently accepted medical use; anti-rescheduling parties attempted to poke holes in the Schedule III recommendation.

DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing

The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.

DEA Judge Sets Cannabis Hearing Schedule, Won’t Consider More Participants

The administrative law judge declined to consider pleas from non-parties to participate in the rescheduling hearing for the proposed Schedule III rule.

Page 1 of 20

Next Page